|
|
|
|
2
*
Laboratory of Human Nutrition, School of Science and Clinical Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139;
Shriners Burns Hospital, Boston, MA 02114; and
**
Phenome Sciences, Incorporated, Woburn, MA 01801
2To whom correspondence should be addressed.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: glutamine glutamate fluxes nitrogen cycle transport carbon metabolism
| INTRODUCTION |
|---|
|
|
|---|
| Physiochemical properties |
|---|
|
|
|---|
|
20 h to form only aspartic acid. | Physiologic functions |
|---|
|
|
|---|
|
In addition to this protein substrate and structural role of glutamine,
this amino acid has been termed a "competence factor" by
Rhoads (1999)
in that it serves to stimulate protein
synthesis (Hammerqvist et al. 1989
, Hickson et al. 1995
, MacLennan et al. 1987
, Smith 1990
) by a mechanism(s) that is still not fully understood, as
well as other systems including intestinal/fluid electrolyte
absorption, intestinal cell proliferation and the mitogenic response to
growth factors. Its role in nitrogen metabolism and as a source of fuel
in various tissues and under various conditions will be considered, in
brief, below. Thus, in a general context, this listing of the functions
of glutamine might be compared with those of glutamate as summarized by
us earlier (Young and Ajami 2000
); both amino acids
fulfill numerous and important functions, some of which may be met by
either one due to their ready metabolic interconversion, although a
number of functions are unique to the specific amino acid. For example,
this latter point applies to the role of glutamate as a taste substance
(Fernstrom and Garattini 2000
, Halpern 2000
, Yamaguchi and Ninomiya 2000
), which is not
shared by glutamine. Similarly, the interorgan nitrogen transport
function is unique to glutamine, at least in comparison with glutamate,
although glutamate-derived alanine is also an important vehicle for
moving nitrogen from muscle to the liver (Elia and Livesey 1983
, Elia et al. 1985
). We will also return to
this function as well as a number of others below as we continue to
develop our answer to the question posed in the title of this paper.
Nevertheless, the breadth of the involvement of both amino acids in
cell function and metabolism is reflected by Purich (1998)
who stated: "Few would quarrel with the assertion that
glutamine is a phenomenally versatile metabolite ... ." Brosnan
(2000
) states in reference to glutamate: "No other
amino acid displays such remarkable versatility!"
| Origins of glutamine |
|---|
|
|
|---|
3.8 or
more billion years ago. Three hypotheses have been proposed to explain
the origin of small organic molecules, including amino acids, as
follows: 1) synthesis in a reducing environment via the
electrical discharge reaction. Glycine and several other naturally
occurring amino acids are prominent products but none of the
"Urey-Miller" type of experiments appear to yield glutamine as a
product, presumably due to its chemical instability as discussed above.
Amino acid polymers may also be detected depending upon the conditions
(Harada 1974
In contrast to the foregoing theories for which some experimental
support has been accumulated, the situation with respect to the
evolution of a self-replicating system in which glutamine and other
amino acids were players is even more tenuous because of the virtual
absence of experimental data (Orgel 1998
). In brief, it
is generally accepted that there was an RNA world in which RNA
molecules functioned as both genetic materials and enzyme-like
catalysts (Freelund et al. 1999
) and that this RNA world
gave rise to the DNA/protein world in which biochemical reactions are
catalyzed by DNA-encoded protein enzymes. Joyce (2000)
offers the view that RNA molecules are lacking when it
comes to chemical diversity of their subunits and that riboenzymes (RNA
molecules that behave as enzymes) cannot match proteins in their
catalytic sophistication, possibly accounting for the replacement of
the RNA world by a genetic system based on DNA and protein. It is also
possible that the RNA world was preceded by a simpler peptide nucleic
acid (Böhler et al. 1995
) or an
(L)-
-threofuranosyl oligonucleotide world (Schöning et al. 2000
) and that metabolism, or substantial organization of
reaction sequences (Morowitz et al. 2000
), may have
preceded genetics as we know it today.
| The carbon and nitrogen cycles |
|---|
|
|
|---|
As depicted in Figure 1
, living organisms can be divided into two large groups according to how
they obtain carbon from the environment; many autotrophs fix carbon
dioxide from the atmosphere via photosynthesis (plants; photosynthetic
bacteria) whereas heterotrophs, including humans, obtain carbon in more
complex forms, which are used as nutrients, and they return
CO2 to the atmosphere. All organisms require
nitrogen; thus, as in the case of carbon, a nitrogen cycle also
operates, in which gaseous nitrogen makes up 80% of the atmosphere.
There are some organisms capable of fixing atmospheric nitrogen into
ammonia, and plants are able to use either the ammonia or soluble
nitrates (that are reduced to ammonia) produced by nitrifying bacteria;
vertebrates must obtain some nitrogen in the form of amino acids and
other N-containing organic compounds. Because glutamate and
glutamine provide a critical entry of the ammonia into the plant and
animal worlds of amino acids and other nitrogen compounds, it is
pertinent to examine, in the context of this nitrogen cycle and the
amino acid economy of the mammalian organism, the contribution that
each amino acid makes.
|
![]() | (1) |
and 2) the glutamate dehydrogenase reaction:
![]() | (2) |
However, because the Km for
NH+4 in this reaction is high or
>1 mmol/L, this reaction is thought to make only a modest contribution
to net ammonia assimilation in the mammalian organism [see
Katagiri and Nakamura (1999)
].
Hence, we need to ask now about net glutamate synthesis. In bacteria
and plant chloroplasts, glutamate is produced by the action of
glutamate synthase, according to the reaction:
![]() | (3) |
The sum of the glutamate synthase (Eq. 3)
and glutamine synthetase
(Eq. 1)
reactions is, therefore:
![]() | (4) |
Hence, the two reactions combined (Eq. 4) give a net synthesis of one molecule of glutamate. But, because glutamate synthetase is not present in animal tissues, a net incorporation of ammonia nitrogen via this nitrogen cycle arises primarily from glutamate rather than from glutamine. A net accumulation of glutamine would be achieved via the glutamine synthetase reaction that uses ammonia, which would be derived from various sources including glutamate, other amino acids or via hydrolysis of urea. Thus, in reference to mammalian nutrition, glutamate is primary to glutamine in the context of a net accumulation of ammonia nitrogen from the nitrogen cycle.
A net incorporation of ammonia could also be achieved via the glycine
synthetase (glycine cleavage) reaction, as follows:
![]() |
The glycine formed might then be incorporated into proteins and
used, for example, for glutathione, creatine or porphyrin synthesis;
via the serine hydroxymethyl transferase reaction, it would also be
converted to serine. The nitrogen of serine would then either be
available for cysteine (and taurine) synthesis or released as ammonia
via the serine dehydratase reaction. Thus, in theory, the
glycine-serine pathway of ammonia incorporation into the amino acid
economy of the organism would have a limited effect on the net input of
nitrogen from ammonia. In any case, the physiologic significance of the
glycine cleavage system appears to be related more to glycine
catabolism than to glycine synthesis (Kikuchi 1973
).
If glutamate is the ruler in the context of making net amino nitrogen
available to the mammalian organism via plant proteins, two issues
arise. First, does the glutamine that is also present in these food
sources serve a specific, indispensable and/or functional role beyond
that of serving as a source of utilizable nitrogen? This is a major
topic for subsequent presentations to answer but we are unaware of any
evidence that there is a specific dietary requirement for glutamine in
healthy humans. Second, given the role of glutamate as a nitrogen
portal for bringing atmospheric nitrogen into mammalian metabolism, is
there an additional and specific dietary need for glutamate provided
sufficient dietary amino nitrogen as alanine and aspartate, for
example, is available for transamination reactions and thus for
glutamate (and then glutamine) synthesis? This question cannot be
answered unequivocally at present, but it is clear that indispensable
amino acids alone, or when in high concentration relative to the
dispensable amino acids, will not support adequate growth in
experimental animals (Rogers and Harper 1965
,
Young and Zamora 1968
) or human infants
(Snyderman et al. 1962
). Hence, we conclude that a
source of preformed
-amino nitrogen from other than the
indispensable amino acids is required by the mammalian organism.
Whether glutamate is actually needed or possibly serves as a more
efficient source of this nitrogen, compared with its homologs
(Young and Ajami 2000
) remains to be determined.
However, Reeds (2000)
has reviewed a number of findings
revealing that diets completely devoid of glutamine and glutamate
result in poorer growth in rats and pigs. This is suggestive of a
dietary requirement for glutamate. However, the new concept that we
offer here is that a dietary
-amino N source is needed beyond that
supplied by the indispensable amino acids and that glycine would not
effectively meet this role for reasons alluded to above. This concept
is firmly based on the question of glutamate synthesis in animals that
was raised recently by Katagiri and Nakamura (1999)
.
| Nitrogen transport |
|---|
|
|
|---|
|
This further raises the thought that the transport function of
glutamine is not restricted to the flow of nitrogen between organs or
simply from the periphery to the splanchnic region. The major
transmitters at excitatory synapses in the central nervous system are
glutamate and acetyl choline, whereas inhibitory signals are carried by
glycine and
-amino butyric acid. This amino acid function might have
evolved >1 billion years ago (Walker et al. 1996
), and
it is now abundantly clear that there is a glutamate-glutamine
cycle in the brain; glutamine serves to return the glutamate that is
removed from the synaptic cleft by astrocytes back to the presynaptic
neuron (Fig. 2
). Two points should be made here, given the more extensive discussion
by Behar and Rothman (2001)
elsewhere in these
Proceedings. First, it appears that the glutamate/glutamine cycle is a
major metabolic flux in rats (Sibson et al. 1998
). In
the human cortex (Table 4
) and in the resting human brain cycle, it seems to account for 80% of
glucose oxidation (Rothman et al. 1999
, Shulman and Rothman 1998
). Second, it is likely that the schema shown
in Figure 2
is incomplete and that a more elaborate picture of synaptic
information flow should now depict glial/neuronal networks because the
two different types of glial cells, astrocytes and oligodendrocyte
precursor cells, appear to be involved in glutamate-mediated
neuronal signaling (LoTurco 2000
). In spite of these
newer details, the involvement of glutamine in the cycle of release and
re-uptake of the excitatory neurotransmitter glutamate appears to
be an established feature of mammalian brain function.
|
|
![]() |
The energy cost of transporting nitrogen as asparagine (the lower
homolog) would be higher than this because asparagine synthetase uses
the amide of glutamine for formation of asparagine from aspartic acid,
as follows:
![]() |
Therefore, not only is ATP required for the asparagine synthetase
reaction with formation of AMP and PPi, but ATP is used for
synthesis of the amide group of glutamine before its use in this
reaction. In sum, this greatly increases the energy cost of
transporting the nitrogen as the amide group of this lower homolog of
glutamine. 2) Glutamine is a neutral amino acid and can
penetrate cell membranes more easily than can charged glutamate.
3) The formation of glutamine for N transport would, in
effect, spare the 5-carbon skeleton of glutamate and, presumably,
-ketoglutarate for supporting tricarboxylic acid cycle
function. 4) Glutamine synthesis scavenges ammonia
more effectively than does the synthesis of glutamate, via glutamic
acid dehydrogenase (GDH). We might remind the reader that use of
reduced NAD(P)H in the GDH reaction means that the energy equivalent of
three ATP is involved because the three electron pairs from NAD(P)H
would produce three ATP via the oxidative phosphorylation reactions.
Evidently, it would not be efficient from an energetic standpoint to
use glutamate as the N-transporting vehicle, a point that
reconfirms the inferences drawn from the earlier discussion of
glutamates thermodynamic properties. Nevertheless, this matter in no
way minimizes the importance of GDH in body function. A recent example
of its significance is emphasized by the report of a new form of
congenital hyperinsulinism characterized by hypoglycemia and
hyperammonemia caused by mutations in the GDH gene that impair the
control of GDH enzyme activity (Stanley et al. 1998
).
| Glutamine, urea synthesis and N excretion |
|---|
|
|
|---|
![]() |
This enzyme is allosterically activated by
N-acetylglutamate and, from this standpoint, glutamine might
be regarded as a regulator of urea synthesis. There is, in mammalian
tissues, another isoform of CPS (CPS II), which is a large
multifunctional cytosolic protein (Hewagama et al. 1999
)
that catalyzes formation of carbamoyl phosphate, as follows:
![]() |
This reaction is involved in the synthesis of the N3 atom of pyrimidine nucleotides, whereas the amide of glutamine is used directly for the formation of the N3 and N9 atoms of purines.
There is a third form of this enzyme (CPS III) that is similar to CPSI,
except glutamine is the N-donor. Apparently the role of this enzyme
in invertebrates and ureoosmotic elasmobranch fish (sharks, skates,
rays) is in the urea cycle (Zalkin and Smith 1998
).
Purine and pyrimidine metabolism referred to above in relation to CPS
II will be mentioned again but here we raise some issues about
glutamine N transport with reference to urea N production. First, there
is zonation of metabolism in the liver; glutamine is taken up by the
periportal cells of the liver in which there is relatively high
glutaminase activity, with the ammonia being directed toward carbamoyl
phosphate synthesis. It is to be noted that acid-base status
profoundly affects the flux of nitrogen from glutamine to ammonia and
urea through the modulation of phosphate-dependent glutaminase
activity (Nissim et al. 1996
, Nissim 1999
). Glutamine formation and release from the liver occurs
principally in the perivenous region; the hepatocytes in this area are
rich in glutamine synthetase (Häussinger 1990
,
Häussinger et al. 1992
, Watford 2000
) (Fig. 3
). Also included in this figure of the zonation of glutamine metabolism
in the liver is the finding of and speculation made by
OSullivan et al. (1998)
concerning arginine metabolism
in the liver. These investigators proposed that dietary arginine, a
portion of which is converted to ornithine in the intestine, repletes
the urea cycle with intermediates in the periportal hepatocytes,
whereas the excess becomes available for catabolism in the perivenous
hepatocytes. This is an interesting speculation and it serves to nicely
integrate glutamine and arginine metabolism with emphasis on the
primacy of ammonia detoxification.
|
100Å. Thermodynamic modeling of these active sites alternatively
docked with asparagine, glutamine and homoglutamine reveals that only
glutamine possesses the correct combination of hydrogen donor, hydrogen
acceptor and HOMO/LUMO energies to permit concerted transamidation.
Although the mitochondrial phosphate-activated glutaminase isoform
of liver has been characterized (Curthoys and Watford 1995
Thus, when 15NH4Cl was
given to healthy adults daily for 5 d before a 24-h tracer study,
during which time the
15NH4Cl was continued, we
(Metges, C. C., Petzke, K. J. and Young, V. R., unpublished data 2000) observed that there was considerable labeling of
one of the N atoms of urea (m + 1 urea) with relatively little labeling
of both N atoms (m + 2 urea). Although this does not prove that
there is tight channeling of the ammonia derived from glutamine into
carbamoyl phosphate because this differential labeling of the urea
could arise by virtue of the fact that there is a differential labeling
of the relevant precursor pools (Brosnan et al. 1996
),
it is certainly indicative of a preferential movement of the ammonia N
into carbamoyl phosphate for urea synthesis. Channeling of
intermediates occurs throughout most of the urea cycle (Watford 1989
) and there is also little doubt that substrate channeling
occurs in a number of enzyme systems (Miles et al. 1999
,
Ovadi and Srere 2000
). Indeed this process (in
which two or more sequential enzymes in a pathway interact to transfer
a metabolite, or intermediate, from one enzyme site to another without
allowing free diffusion of the metabolite into bulk solvent) may be,
according to Anderson (1999)
, a general feature of
biochemistry and of fundamental importance to the overall control and
catalytic efficiency of multifunctional enzymes and enzyme complexes.
Parenthetically, the physiologic importance of enzyme location and
specific enzyme interactions is illustrated dramatically by the work of
Wojtas et al. (1997),
reviewed by Srere and Knull (1998)
, showing that mutations in the Drosophila
melanogaster glycerol phosphate dehydrogenase (GPDH) gene yield a
flightless phenotype and that this is due to cellular mislocation of
GPDH, aldolase and glyceraldehyde 3-phosphate dehydrogenase.
Finally, with respect to glutamine and nitrogen excretion,
humans, as for other terrestrial vertebrates, are ureotelic, in which
the principal route of nitrogen loss is via urea formation and
elimination. Aquatic animals, for which water is more plentiful, are
ammonotelic or ammonia excreting. However, in birds or terrestrial
reptiles, excess nitrogen is eliminated via purine synthesis and then
uric acid formation (uricotelic) (Lehninger et al. 1993
). In this last-mentioned case, glutamine is a major
intermediate in the elimination of nitrogen, whereas in humans, this
route of N loss is a relatively minor one. Hence, this is not a major
intermediary function of glutamine in reference N homeostasis in humans
although important in other species.
| Glutamine and C-commerce |
|---|
|
|
|---|
5% of systemic glucose
appearance, and renal production of glucose from glutamine accounted
for nearly 75% of all glucose derived from glutamine. The kidney
accounts for
4050% of overall gluconeogenesis under
postabsorptive conditions (Gerich et al. 2000
|
|
This brings us to another point, namely, the speculation that glutamine
exists to deliver glutamate for 5 C-commerce. We further would
argue the following: 1) this function is especially
important under conditions of increased energy need and in which
anoxia, hypoxia or dysoxia exists, that is, conditions that cause
fluctuations in intracellular pH and bicarbonate ion; and 2)
glutamine would meet this role better than glutamate, again with
reference to its relative thermodynamic constancy relative to
ionization state. Further, because glutamine can enter the cell against
a proton gradient, it would not interfere with cyst(e)ine and sulfur
amino acid metabolism, as discussed by Dröge and Holm (1997)
. Indeed, there is some limited evidence that glutamine
serves as a key anapleurotic and energy-yielding substrate in
hypoxia, anoxia and dysoxia. For example, Khogali et al. (1998)
, using a cardiac ischema-reperfusion model
(Rennie et al. 1996
), showed a reduced cardiac flow,
decreased ATP and glutamate concentrations and increased lactate when
the perfusion medium did not contain glutamine and that addition of the
amino acid prevented these changes. In anoxia, mitochondria change from
being ATP producers to powerful ATP consumers (St. Pierre et al. 2000
). Thus, Weinberg et al. (2000)
found that
the mitochondrial lesion, membrane permeability transit and cytochrome
C leakage in ischemic/hypoxic cell injury was prevented by citric acid
cycle metabolites that anaerobially generate ATP via
substrate-level phosphorylation. The substrates they examined
included
-ketoglutarate and aspartic acid. It seems likely,
therefore, that glutamine could serve as the source of
-ketoglutarate in relation to this process.
Finally, the question might be raised whether the role of glutamine in
reference to 5 C-commerce might be by-passed. Here, we
speculate that ornithine might substitute for glutamine in this role,
under certain conditions. It is known that the
-ketoglutarate salt
of ornithine improves N homeostasis, sustains muscle glutamine and
increases plasma glutamine in surgical patients (Cynober et al. 1987
, Cynober 1999
, DeBandt et al. 1998
). Further, we have shown that ornithine is readily
oxidized in healthy adults (Castillo et al. 1994
) and in
severely burned patients (Yu et al. 2001
),
leading to a suggestion that this amino acid might be an effective
substitute for glutamine with respect to its role in 5 C-commerce.
This will require additional investigation under defined conditions of
tissue oxygen availability and ATP status.
| CONCLUSIONS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
3 Abbreviations used: CPSI, carbamoyl phosphate
synthetase; GDH, glutamic acid dehydrogenase; GPDH, glycerol phosphate
dehydrogenase; HOMO, highest occupied molecular orbital; LUMO, lowest
unoccupied molecular orbital. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Abcouwer S. F. & Souba W. W. (1999) Is glutamine a pretender to the throne?. Nutrition 15:71-72.[Medline]
2. Anderson K. (1999) Fundamental mechanisms of substrate channeling. Methods Enzymol 308:111-145.[Medline]
3.
Battezzati A., Brillon D. J. & Matthews D. E. (1995) Oxidation of glutamic acid by the splanchnic bed in humans. Am. J. Physiol. 269:E269-E276.
4.
Behar K. L. & Rothman D. L. (2001) In vivo NMR studies of glutamate-GABA-glutamine cycling in rodent and human cortex: the central role of glutamine. J. Nutr. 131:2498S-2504S.
5. Böhler C., Nielsen P. E. & Orgel L. E. (1995) Template switching between PNA and RNA oligonucleotides. Nature (Lond.) 376:578-581.[Medline]
6. Brosnan J. T. (2000) Glutamate, at the interface between amino acid and carbohydrate metabolism. J. Nutr. 130:988S-990S.
7.
Brosnan J. J., Brosnan M. E., Charron R. & Nissim I. (1996) A mass isotopomer study of urea and glutamine synthesis from 15N-labeled ammonia in the perfused rat liver. J. Biol. Chem. 271:16199-16207.
8. Butterworth R. F. (1998) Effects of hyperammonemia on brain function. J. Inherit. Metab. Dis. 21(suppl. 1):6-20.
9.
Carmichael J., Chatellier J., Woolfson J. A., Milstein C., Fersht A. R. & Rubinstein D. C. (2000) Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntingtons disease. Proc. Natl. Acad. Sci. U.S.A. 97:9701-9705.
10.
Castillo L, Sànchez M., Chapman T. E., Ajami A., Burke J. F. & Young V. R. (1994) The plasma flux and oxidation rate of ornithine adaptively decline with restricted arginine intake. Proc. Natl. Acad. Sci. U.S.A. 91:6393-6397.
11. Cody G. D., Boctor N. Z., Filley T. R., Hazen R. M., Scott J. H., Sharma A. & Yoder H. S., Jr (2000) Primordial carboxylated iron-sulfur compounds and the synthesis of pyruvate 2000 Science (Washington DC) 289 13371340. .
12.
Consoli A., Nurjhan N., Reilly J. J., Jr, Bier D. M. & Geich J. E. (1990) Contribution of liver and skeletal muscle to alanine and lactate metabolism in humans. Am. J. Physiol. 259:E677-E684.
13. Curthoys N. P. & Watford M. (1995) Regulation of glutaminase activity and glutamine metabolism. Annu. Rev. Nutr. 15:133-159.[Medline]
14.
Cynober L. A. (1999) The use of
-ketoglutarate salts in clinical nutrition and metabolic care. Clin. Care Metab. Care 2:33-37.
15. Cynober L., Lioret N., Covdray-Lucas C., Aussel C., Ziegler F., Baudin B., Saizy R. & Giboudeau J. (1987) Action of ornithine alpha-ketoglutarate on protein metabolism in burn patients. Nutrition 3:187-191.
16. Daikhin Y. & Yudkoff M. (2000) Compartmentation of brain glutamate metabolism in neurons and glia. J. Nutr. 130:1026S-1031S.
17.
Darmaun D., Matthews D. E. & Bier D. M. (1986) Glutamine and glutamate kinetics in humans. Am. J. Physiol. 251:E117-E126.
18.
DeBandt J.-P., Covdray-Lucas C., Lioret N., Lim S. K., Saizy R., Giboudeau J. & Cynober L. (1998) A randomized controlled trial of the influence of the mode of enteral ornithine
-ketoglutarate administration in burn patients. J. Nutr. 128:563-569.
19. Dröge W. & Holm E. (1997) Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction. FASEB J 11:1077-1089.[Abstract]
20. Elia M. & Livesey G. (1983) Effects of ingested steak and infused leucine on forelimb metabolism in man and the fate of the carbon skeletons and amino groups of branched-chain amino acids. Clin. Sci. (Lond.) 64:517-526.[Medline]
21. Elia M., Neale G. & Livesey G. (1985) Alanine and glutamine release from the human forearm: effects of glucose administration. Clin. Sci. (Lond.) 69:123-133.[Medline]
22. Fernstrom J. D. Garattini S. eds. Proceedings of the International Symposium on Glutamate J. Nutr 130 (suppl.):891S-1079S .
23.
Freelund S. J., Knight R. D. & Landweber L.-F. (1999) Do proteins predate DNA?. Science (Washington DC) 286:690-692.
24. Gerich J. E., Meyer C. & Stumvoll M. V. (2000) Hormonal control of renal and systemic glutamine metabolism. J. Nutr. 130:995S-1001S.
25.
Haisch M., Fukagawa N. K. & Matthews D. E. (2000) Oxidation of glutamine by the splanchnic bed in humans. Am. J. Physiol. 278:E593-E602.
26. Halpern B. P. (2000) Glutamate and the flavor of foods. J. Nutr. 130:910S-914S.
27. Hammerqvist F., Wernerman J., Ali R., Von Der Decken A. & Vinnars E. (1989) Addition of glutamine to total parenteral nutrition after elective abdominal surgery spares free glutamine in muscle, counteracts the fall in muscle protein synthesis, and improves nitrogen balance. Ann. Surg. 209:455-461.[Medline]
28. Harada K. (1974) Synthesis of amino acids and peptides under possible prebiotic conditions. Weinstein B. eds. Chemistry and Biochemistry of Amino Acids, Peptides and Proteins 2:297-351 Marcel Dekker New York, NY. .
29. Häussinger D. (1990) Nitrogen metabolism in liver: structural and functional organization and physiological relevance. Biochem. J. 267:281-290.[Medline]
30. Häussinger D., Lomers W. H. & Moorman A.F.M. (1992) Hepatocyte heterogeneity in the metabolism of amino acids and ammonia. Enzyme 46:72-93.[Medline]
31.
Hewagama A., Guy H. I., Vickrey J. F. & Evans D. R. (1999) Functional linkage between the glutaminase and synthetase domains of carbamoyl-phosphate synthetase. J. Biol. Chem. 274:28240-28245.
32.
Hickson R. C., Czerwinski S. M. & Wegrzyn L. E. (1995) Glutamine prevents downregulation of myosin heavy chain synthesis and muscle atrophy from glucocorticoids. Am. J. Physiol. 268:E730-E734.
33. Holden H. M., Thoden J. B. & Raushel F. M. (1998) Carbamoyl phosphate synthetase: a tunnel runs through it. Curr. Opin. Struct. Biol. 8:679-685.[Medline]
34.
Huber C. & Wachterschaüser G. (1998) Peptides by activation of amino acids with CO on (Ni, Fe)S surfaces: implications for the origin of life. Science (Washington, DC) 281:670-672.
35.
Irion R. (2000) The science of astrobiology takes shape. Science (Washington DC) 288:603-605.
36.
Jackson N. C., Carroll P. V., Russell-Jones D. L., Sonksen P. H., Treacher D. F. & Umpleby A. M. (1999) The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism. Am. J. Physiol. 276:E163-E170.
37. James L. A., Lunn P. G., Middleton S. & Elia M. (1998) Distribution of glutaminase and glutamine synthetase activities in the human gastrointestinal tract. Clin. Sci. (Lond.) 94:313-319.[Medline]
38.
Joyce G. F. (2000) Ribozyme evolution at the crossroads. Science (Washington DC) 289:401-402.
39. Karelson M. (2000) Molecular Descriptors in QSAR/QSPR 2000 Wiley New York, NY. .
40. Katagiri M. & Nakamura M. (1999) Is there really any evidence indicating that animals synthesize glutamate?. Biochem. Educ. 27:83-85.
41. Khogali S.E.O., Harper A. A., Lyoll J. A. & Rennie M. J. (1998) Effects of L-glutamine on post-ischaemic cardiac function: protection and rescue. J. Mol. Cell Cardiol. 30:819-827.[Medline]
42. Kikuchi G. (1973) The glycine cleavage system: composition, reaction mechanism and physiological significance. Mol. Cell. Biochem. 1:169-187.[Medline]
43.
Lee W.-J., Hawkins R. A., Vina J. R. & Peterson D. R. (1998) Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal. Am. J. Physiol 274:C1101-C1107.
44. Lehninger A. L., Nelson D. I. & Cox M. M. (1993) Principles of Biochemistry 2nd ed. 1993 Worth Publishers New York, NY. .
45.
LoTurco J. J. (2000) Neural circuits in the 21st century: synaptic networks of neurons and glia. Proc. Natl. Acad. Sci. U.S.A. 97:8196-8197.
46. MacLennan P. A., Brown R. A. & Rennie M. J. (1987) A positive relationship between protein synthetic rate and intracellular glutamine concentration in perfused rat skeletal muscle. FEBS Lett 215:187-191.[Medline]
47.
Matthews D. E. & Campbell R. G. (1992) The effect of dietary protein intake on glutamine and glutamate nitrogen metabolism in humans. Am. J. Clin. Nutr. 55:963-970.
48. McCauley R., Kong S.-E., Heel K. & Hall J. C. (1999) The role of glutaminase in the small intestine. Int. J. Biochem. Cell Biol. 31:405-413.[Medline]
49. Meijer A. J. (1985) Channeling of ammonia from glutaminase to carbamoyl phosphate synthetase in liver mitochondria. FEBS Lett 191:249-251.[Medline]
50.
Metges C. C., El-Khoury A. E., Henneman L., Petzke K. J., Grant I., Bedri S., Pereira P. P., Ajami A. M., Fuller M. F. & Young V. R. (1999a) Availability of intestinal microbial lysine to lysine homeostasis in human subjects. Am. J. Physiol. 277:E597-E607.
51.
Metges C. C., Petzke K. J., El-Khoury A. E., Henneman L., Grant I., Bedri S., Regan M. M., Fuller M. F. & Young V. R. (1999b) Incorporation of urea and ammonia nitrogen into ileal and fecal microbial proteins and plasma free amino acids in normal men and ileostomates. Am. J. Clin. Nutr. 70:1046-1058.
52.
Miles E. W., Rhee S. & Davies D. R. (1999) The molecular basis of substrate channeling. J. Biol. Chem. 274:12193-12196.
53.
Mittendorfer B., Gore D. C., Herndon D. N. & Wolfe R. R. (1999) Accelerated glutamine synthesis in critically ill patients cannot maintain normal intramuscular free glutamine concentration. J. Parent. Enteral Nutr 23:243-250.
54.
Morowitz H. J., Kostelnik J. D., Yang J. & Cody G. D. (2000) The origin of intermediary metabolism. Proc. Natl. Acad. Sci. U.S.A. 97:7704-7708.
55.
Newsholme E. A., Crabtree B. & Ardawi M.S.M. (1985) Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q. J. Exp. Physiol. 70:473-489.
56. Newsholme E. A., Newsholme P., Curi R., Challoner E. & Ardawi M.S.M. (1988) A role for muscle in the immune system and its importance in surgery, trauma, sepsis and burns. Nutrition 4:261-268.
57.
Nissim I. (1999) Newer aspects of glutamic/glutamate metabolism: the role of acute pH changes. Am. J. Physiol. 277:F493-F497.
58.
Nissim I., Yudkoff M. & Brosnan J. T. (1996) Regulation of [15N]urea synthesis from [5-15N]glutamine. Role of pH, hormones and pyruvate. J. Biol. Chem 271:31234-31242.
59. Nurjhan N., Bucci A., Perriello G., Stumvoll M., Dailey G., Bier D. M., Toft I., Jenssen T. G. & Gerich J. E. (1995) Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man. J. Clin. Investig. 95:272-277.
60. Orgel L. E. (1998) The origin of lifea review of facts and speculations. Trends Biochem. Sci. 23:491-495.[Medline]
61. OSullivan D., Brosnan J. T. & Brosnan M. E. (1998) Hepatic zonation of the catabolism of arginine and ornithine in the perfused liver. Biochem. J. 330:627-632.
62. Ovadi J. & Srere P. A. (2000) Macromolecular compartmentation and channeling. Int. Rev. Cytol. 192:255-279.[Medline]
63. Paulson H., Bonini N. & M & Roth K. A. (2000) Polyglutamine disease and neuronal death 2000 Proc. Natl. Acad. Sci U.S.A. 97 1295712958. .
64.
Perriello G., Jorde R., Nurjhan N., Stumvoll M., Dailey G., Jenssen J., Bier D. M. & Gerich J. E. (1995) Estimation of glucose-alanine-lactate-glutamine cycles in postabsorptive humans: role of skeletal muscle. Am. J. Physiol. 269:E443-E450.
65. Perutz M. F. (1999) Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem. Sci. 24:58-63.[Medline]
66. Purich D. L. (1998) Advances in the enzymology of glutamine synthesis. Purich D. L. eds. Advances Enzymology Related Areas Molecular Biology, Amino Acid Metabolism Part A 2:9-42 John Wiley & Sons New York, NY .
67. Raushel F. M., Thoden J. B., Reinhart G. D. & Holden H. M. (1998) Carbamoyl phosphate synthetase: a crooked path from substrates to products. Curr. Opin. Chem. Biol. 2:624-632.[Medline]
68.
Reeds P. J. (2000) Dispensable and indispensable amino acids for humans. J. Nutr. 130:1835S-1840S.
69.
Reeds P. J. & Burrin D. G. (2001) Glutamine and the bowel. J. Nutr. 131:2505S-2508S.
70. Reeds P. J., Burrin D. G., Stoll B. & Jahoor F. (2000) Intestinal glutamate metabolism. J. Nutr. 130:978S-982S.
71. Rennie M. J., Ahmed A., Khogali S.E.O., Low S. Y., Handal H. S. & Taylor P. M. (1996) Glutamine metabolism and transport in skeletal muscle and heart and their clinical relevance. J. Nutr. 126:1142S-1149S.
72. Rhoads M. (1999) Glutamine signaling in intestinal cells. J. Parent. Enteral Nutr. 23:S38-S40.
73. Rogers Q. R. & Harper A. E. (1965) Amino acid diets and maximal growth in the rat. J. Nutr. 87:267-273.
74.
Rothman D. L., Sibson N. R., Hyder F., Shen J., Behar K. L. & Shulman R. G. (1999) In vivo nuclear magnetic resonance spectroscopy studies on the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics. Phil. Trans. R. Soc. Lond. B 354:1165-1177.
75. Sandberg M., Eriksson L., Johsson J., Sjostrom M. & Wold S. (1998) New chemical descriptors relevant for the design of biologically active peptides. A Multivariate characterization of 87 amino acids. J. Med. Chem 41:2481-2491.[Medline]
76.
Satyal S. H., Schmidt E., Kitagawa K., Sondheimer N., Lindquist S., Kramer J. M. & Morimoto R. J. (2000) Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A 97:5750-5755.
77.
Schöning K.-U., Scholz P., Guntha S., Wu X., Krishnamurthy R. & Eschenmoser A. (2000) Chemical etiology of nucleic acid structure: the
-threofuranosyl-(3'
2') oligonucleotide system. Science (Washington, DC) 290:1347-1351.
78.
Shen J., Petersen K. F., Behar K. L., Brown P., Nixon T. W., Mason G. F., Petroff O.A.C., Shulman G. I., Schulman R. G. & Rothman D. L. (1999) Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc. Natl. Acad. Sci. U.S.A. 96:8235-8240.
79.
Shulman R. G. & Rothman D. L. (1998) Interpreting functional imaging studies in terms of neurotransmitter cycling. Proc. Natl. Acad. Sci. U.S.A. 95:11993-11998.
80.
Sibson N. R., Dhankhar A., Mason G. F., Rothman D. R., Behar K. L. & Shulman R. G. (1998) Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc. Natl. Acad. Sci. U.S.A. 95:316-321.
81. Smith R. J. (1990) Glutamine metabolism and its physiological function. J. Parent. Enteral Nutr. 14:40S-44S.
82. Snyderman S. E., Holt L. E., Jr, Dancis J., Roitman E., Boyer A. & Balis M. E. (1962) "Unessential" nitrogen: a limiting factor for human growth. J. Nutr. 78:57-72.
83. Souba W. W. (1991) Glutamine: a key substrate for the splanchnic bed. Annu. Rev. Nutr. 11:285-309.[Medline]
84. Srere P. A. & Knull H. R. (1998) Location-location-location. Trends Biochem. Sci. 23:319-320.[Medline]
85.
St. Pierre J., Brand M. D. & Boutilier R. G. (2000) Mitochondria as ATP consumers: cellular treason in anoxia. Proc. Natl. Acad. Sci. U.S.A. 97:8670-8674.
86.
Stanley C. A., Lieu Y. K., Hsu B.Y.L., Burlina A. B., Greenberg C. R., Hopwood N. J., Perlman K., Rich B. H., Zammarchi E. & Poncz M. (1998) Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N. Engl. J. Med. 338:1352-1357.
87.
Stumvoll M., Meyer C., Perriello G., Kreider M., Welle S. & Gerich J. (1998) Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am. J. Physiol. 274:E817-E826.
88. Stumvoll M., Perriello G., Meyer C. & Gerich J. (1999) Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney Int 55:778-779.[Medline]
89. Thoden J. B., Holden H. M., Wesenberg G., Raushel F. M. & Rayment I. (1997) Structure of carbamoyl phosphate synthetase: a journey of 96Å from substrate to product. Biochemistry 36:6305-6316.[Medline]
90. van Acker B.A.C., Holsewe K.W.E., Wagenmaker A.J.M., Deutz N.E.P., van Kreel B. K., Halliday D., Matthews D. E., Soeters P. B. & Von Meyenfeldt M. F. (1998) Absence of glutamine isotopic steady state: implications for the assessment of whole-body glutamine production rate. Clin. Sci. (Lond.) 95:339-346.[Medline]
91. van Acker B.A.C., von Meyenfeldt M. F., van der Hulst R.R.W.J., Hulsewé K.W.E., Wagenmakers A.J.M., Deutz N.E.P., Blaauw I., Dejong C. H., van Kreel B. K. & Soeters P. B. (1999) Glutamine: the pivot of our nitrogen economy?. J. Parent. Enteral Nutr 23:S45-S48.
92. Wachterschaüser G. (1992) Groundworks for an evolutionary biochemistry: the iron-sulfur world. Prog. Biophys. Mol. Biol. 58:85-201.[Medline]
93. Wachterschaüser G. (1994) Life in a ligand sphere 1994 Proc. Natl. Acad. Sci U.S.A. 91 42834287. .
94. Wachterschaüser G. (2000) Life as we dont know it. Science (Washington DC) 298:1307-1308.
95. Walker R. J., Brooks H. L. & Holden-Dye L. (1996) Evolution and overview of classical transmitter molecules and their receptors. Parasitology 113(suppl.):S3-S33.
96. Watford M. (1989) Channeling in the urea cycle: a metabolon spanning two compartments. Trends Biochem. Sci. 14:313-314.[Medline]
97. Watford M. (2000) Glutamine and glutamate metabolism across the liver sinusoid. J. Nutr. 130:983S-987S.
98.
Weinberg J. M., Venkatachalam M. A., Roeser N. F. & Nissim I. (2000) Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc. Natl. Acad. Sci. U.S.A. 97:2826-2831.
99. Windmueller H. G. (1982) Glutamine utilization by the small intestine. Adv. Enzymol. Relat. Areas Mol. Biol. 53:201-237.[Medline]
100. Wojtas K., Slepecky N., von-Kalm L. & Sullivan D. (1997) Flight muscle function in Drosophila requires colocalization of glycolytic enzymes. Mol. Biol. Cell 8:1665-1675.[Abstract]
101. Yamaguchi S. & Ninomiya K. (2000) Umami and food palatability. J. Nutr. 130:921S-926S.
102.
Yang R. D., Matthews D. E., Bier D. M., Lo C. & Young V. R. (1984) Alanine kinetics in humans: influence of different isotopic tracers. Am. J. Physiol 247:E634-E638.
103.
Yarasheski K. E., Zachwieja J. J., Gischler J., Crowley J., Horgan M. M. & Powderly W. G. (1998) Increased plasma Gln and Leu Ra and inappropriately low muscle protein synthesis rate in AIDS wasting. Am. J. Physiol. 275:E577-E583.
104. Young V. R. & Ajami A. M. (2000) Glutamate: an amino acid of particular distinction. J. Nutr. 130:892S-900S.
105. Young V. R. & Zamora J. (1968) Effects of altering the proportions of essential to non-essential amino acids on growth and plasma amino acids in the rat. J. Nutr. 96:21-27.
106.
Yu Y.-M., Ryan C. M., Castillo L., Lu X.-M., Beaumier L., Tompkins R. G. & Young V. R. (2001) Arginine and ornithine kinetics in severely burned patients; increased rate of arginine disposal. Am. J. Physiol. 280:E509-E517.
107. Zalkin H. & Smith J. (1998) Enzymes utilizing glutamine as an amide donor. Purich D. L. eds. Advances Enzmology Related Areas Molecular Biology, Amino Acid Metabolism Part A 2:87-144 John Wiley & Sons New York, NY .
This article has been cited by other articles:
![]() |
Z. Zhang, A. Gameiro, and C. Grewer Highly Conserved Asparagine 82 Controls the Interaction of Na+ with the Sodium-coupled Neutral Amino Acid Transporter SNAT2 J. Biol. Chem., May 2, 2008; 283(18): 12284 - 12292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kadrofske, P. S. Parimi, L. L. Gruca, and S. C. Kalhan Effect of intravenous amino acids on glutamine and protein kinetics in low-birth-weight preterm infants during the immediate neonatal period Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E622 - E630. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nakamura and S. J. Hagen Role of glutamine and arginase in protection against ammonia-induced cell death in gastric epithelial cells Am J Physiol Gastrointest Liver Physiol, December 1, 2002; 283(6): G1264 - G1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nissim, O. Horyn, Y. Daikhin, I. Nissim, A. Lazarow, and M. Yudkoff Regulation of urea synthesis by agmatine in the perfused liver: studies with 15N Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1123 - E1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van Milgen Modeling Biochemical Aspects of Energy Metabolism in Mammals J. Nutr., October 1, 2002; 132(10): 3195 - 3202. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||